Vitality Watch

Dossier pubmed preclinical 13-nov-2026
Animal model, organoid, or cell-culture result — not yet human

Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation.

Key claim: Leptin receptor haploinsufficiency accelerates age-dependent metabolic decline and Alzheimer-like neuropathology through CDK5 hyperactivation and synaptic gene downregulation in mice.

Abstract

Leptin receptor (LEPR) signaling plays a critical role in neuronal survival and synaptic function and is increasingly implicated in Alzheimer’s disease (AD) pathogenesis. Beyond its metabolic actions, leptin regulates β-amyloid homeostasis, tau phosphorylation, and synaptic plasticity. While the neurological consequences of homozygous leptin receptor (Lepr) mutations are well characterized, the impact of heterozygous Lepr deficiency on brain aging and neurodegeneration remains unclear. To address this, we analyzed heterozygous leptin receptor mutant (db/+) mice at 6 and 12 months of age using metabolic, behavioral, biochemical, neuropathological, and transcriptomic approaches. Young db/+ mice were comparable to controls, whereas aged db/+ mice developed obesity, impaired glucose tolerance, and insulin resistance, accompanied by deficits in spatial learning and motor coordination. Aged db/+ brains exhibited elevated amyloid-β42 levels, increased CDK5 kinase activity, and hyperphosphorylation of tau at Ser396 and Thr231. Although total LEPR protein levels were unchanged, phosphorylation of STAT3 at Tyr705 was significantly reduced, indicating impaired downstream LEPR signaling. Transcriptomic profiling revealed downregulation of genes involved in synaptic signaling and plasticity, including Gabrb2, Brsk1, Camk2a, Syn1, and Syngap1, along with alterations in neurotransmitter and oxidative phosphorylation pathways. Collectively, these findings demonstrate that leptin receptor haploinsufficiency promotes age-dependent metabolic dysfunction, synaptic failure, and CDK5-mediated tauopathy, leading to Alzheimer-like neurodegeneration and identifying LEPR as a potential genetic risk factor and therapeutic target.

Why this matters

[animal-model] This study identifies partial leptin receptor deficiency as an age-dependent link between metabolic dysfunction and Alzheimer-like neuronal pathology in mice, despite a relatively mild phenotype in youth. [animal-model] The reported CDK5 and synaptic changes extend the nutrient-sensing causal picture beyond mTOR, but do not establish the same pathway in human aging or demonstrate that leptin-directed or CDK5-targeted treatment prevents human neurodegeneration.

Source

Link

Briefing card

Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation.
Stage: preclinical · pubmed · 13-nov-2026

Leptin receptor haploinsufficiency accelerates age-dependent metabolic decline and Alzheimer-like neuropathology through CDK5 hyperactivation and synaptic gene downregulation in mice.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.jbc.2026.113749

build build 880 · 2bcef25 · 2026-11-18